ZNF198 inhibitors represent a class of compounds that target the ZNF198 protein, a zinc finger protein involved in various cellular processes, particularly transcriptional regulation. ZNF198 is characterized by its multiple zinc finger domains, which enable it to bind to specific DNA sequences and interact with other proteins, including those involved in chromatin remodeling and transcriptional machinery. Inhibitors of ZNF198 typically interfere with its ability to modulate gene expression, often by disrupting its zinc finger domains' interaction with DNA or associated protein partners. This interference can lead to altered cellular processes, such as changes in gene transcription, which may impact cell growth, differentiation, and signaling pathways. Since ZNF198 plays a role in the regulation of gene expression, its inhibitors are of particular interest in understanding the precise molecular mechanisms governing transcription and chromatin organization.
The chemical structure of ZNF198 inhibitors is designed to interact specifically with the zinc finger motifs, either by directly binding to the zinc coordination site or by preventing protein-protein interactions essential for its function. These inhibitors may also affect the post-translational modifications of ZNF198, such as phosphorylation or ubiquitination, which are critical for its activity and stability within the cell. The specificity and potency of ZNF198 inhibitors are often fine-tuned by modifying their molecular scaffolds to optimize their interaction with the zinc finger domains. As research continues, ZNF198 inhibitors provide valuable tools for dissecting the complex roles of zinc finger proteins in cellular biology, offering insights into the regulatory networks that control gene expression and chromatin dynamics.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially affecting gene expression patterns and indirectly influencing ZMYM2 activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase (HDAC) inhibitor, which may alter chromatin structure and gene expression, potentially impacting ZMYM2. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another HDAC inhibitor, potentially affecting gene regulation and indirectly influencing ZMYM2 activity. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor, which can alter gene expression and potentially impact ZMYM2. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, affects DNA methylation and gene expression, potentially influencing ZMYM2. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective HDAC inhibitor, which may have implications for gene regulation involving ZMYM2. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A BET bromodomain inhibitor, potentially influencing gene expression and regulatory mechanisms involving ZMYM2. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
Another BET bromodomain inhibitor, which can affect transcription regulation, potentially impacting ZMYM2. | ||||||
A-366 | 1527503-11-2 | sc-507495 | 10 mg | $195.00 | ||
A G9a/GLP histone methyltransferase inhibitor, potentially altering epigenetic marks and gene expression relevant to ZMYM2. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
A selective EZH2/EZH1 inhibitor, potentially affecting gene expression patterns relevant to ZMYM2. | ||||||